CAR-T and Lymphoma – Michael Jain, MD, and Robert Figlin, MD, discuss the role of CAR-T in the treatment of lymphoma

CAR-T and Lymphoma – Michael Jain, MD, and Robert Figlin, MD, discuss the role of CAR-T in the treatment of lymphoma

Saturday December 21, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Michael Jain, MD, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, discuss the role of CAR-T and the treatment of lymphoma and off-the-shelf CAR-T

Featured Videos

Ahmed Kaseb, MD, on combining cabozantinib with checkpoint inhibitors for treatment of HCC

Nevena Damjanov, MD, explains the outcomes of combining atezolizumab with bevacizumab in 1st line HCC patients

Nevena Damjanov, MD, shares personal opinion of treatment of patient with a high expression of AFP